These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15821821)

  • 1. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors.
    Arikan E; Sen S
    Clin Appl Thromb Hemost; 2005 Apr; 11(2):147-59. PubMed ID: 15821821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
    Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects.
    Foss CH; Vestbo E; Frøland A; Ingerslev J; Gjessing HJ; Mogensen CE; Damsgaard EM
    J Intern Med; 2002 Aug; 252(2):155-63. PubMed ID: 12190891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW; Blann AD; Lip GY
    Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
    Mansfield MW; Heywood DM; Grant PJ
    Circulation; 1996 Nov; 94(9):2171-6. PubMed ID: 8901668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
    Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
    J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.
    Wu O; Leng JH; Yang FF; Yang HM; Zhang H; Li ZF; Zhang XY; Yuan CD; Li JJ; Pan Q; Liu W; Ren YJ; Liu B; Liu QM; Cao CJ
    Clin Exp Hypertens; 2018; 40(1):16-21. PubMed ID: 29083240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive patients with carotid artery plaque exhibit increased platelet aggregability.
    Fusegawa Y; Hashizume H; Okumura T; Deguchi Y; Shina Y; Ikari Y; Tanabe T
    Thromb Res; 2006; 117(6):615-22. PubMed ID: 15993474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Spencer CG; Gurney D; Felmeden DC; Blann AD; Beevers DG; Lip GY
    J Intern Med; 2004 Jan; 255(1):59-67. PubMed ID: 14687239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone and acute stress are associated with fibrinogen and von Willebrand factor in African men: the SABPA study.
    Malan NT; von Känel R; Schutte AE; Huisman HW; Schutte R; Smith W; Mels CM; Kruger R; Meiring M; van Rooyen JM; Malan L
    Int J Cardiol; 2013 Oct; 168(5):4638-42. PubMed ID: 23953632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.
    Varughese GI; Patel JV; Tomson J; Lip GY
    Heart; 2007 Apr; 93(4):495-9. PubMed ID: 17005711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic status and determinants of hemostatic function in healthy women.
    Wamala SP; Murray MA; Horsten M; Eriksson M; Schenck-Gustafsson K; Hamsten A; Silveira A; Orth-Gomér K
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):485-92. PubMed ID: 10073947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
    Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
    Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.
    Michels A; Swystun LL; Mewburn J; Albánez S; Lillicrap D
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.